Related references
Note: Only part of the references are listed.A Bayesian seamless phase I-II trial design with two stages for cancer clinical trials with drug combinations
Jose L. Jimenez et al.
BIOMETRICAL JOURNAL (2020)
A Bayesian Adaptive Design in Cancer Phase I Trials Using Dose Combinations with Ordinal Toxicity Grades
Marcio A. Diniz et al.
STATS (2020)
Cancer phase I trial design using drug combinations when a fraction of dose limiting toxicities is attributable to one or more agents
Jose L. Jimenez et al.
BIOMETRICAL JOURNAL (2019)
A flexible design for advanced Phase I/II clinical trials with continuous efficacy endpoints
Pavel Mozgunov et al.
BIOMETRICAL JOURNAL (2019)
Phase I/II dose-finding design for molecularly targeted agent: Plateau determination using adaptive randomization
Marie-Karelle Riviere et al.
STATISTICAL METHODS IN MEDICAL RESEARCH (2018)
Dose escalation with over-dose and under-dose controls in Phase I/II clinical trials
Zhengjia Chen et al.
CONTEMPORARY CLINICAL TRIALS (2015)
Escalation with Overdose Control is More Efficient and Safer than Accelerated Titration for Dose Finding
Andre Rogatko et al.
ENTROPY (2015)
Using Data Augmentation to Facilitate Conduct of Phase I-II Clinical Trials With Delayed Outcomes
Ick Hoon Jin et al.
JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION (2014)
Dose-Finding Based on Bivariate Efficacy-Toxicity Outcome Using Archimedean Copula
Yuxi Tao et al.
PLOS ONE (2013)
Dose escalation with overdose control using a quasi-continuous toxicity score in cancer Phase I clinical trials
Zhengjia Chen et al.
CONTEMPORARY CLINICAL TRIALS (2012)
An adaptive dose-finding approach for correlated bivariate binary and continuous outcomes in phase I oncology trials
Akihiro Hirakawa
STATISTICS IN MEDICINE (2012)
A novel toxicity scoring system treating toxicity response as a quasi-continuous variable in Phase I clinical trials
Zhengjia Chen et al.
CONTEMPORARY CLINICAL TRIALS (2010)
Unifying CRM and EWOC designs for phase I cancer clinical trials
Pei-Ling Chu et al.
JOURNAL OF STATISTICAL PLANNING AND INFERENCE (2009)
Critical aspects of the Bayesian approach to phase I cancer trials
Beat Neuenschwander et al.
STATISTICS IN MEDICINE (2008)
Share Paper
